ARCHIVES

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 19 | May 16, 2008

Download PDF Visit The Full Archive

Related Articles

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Working Group Proposes “Equitable” Schema For Determining Cancer Center Core Grants

July 3, 2013

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009

Regions Outlined In CIS Proposal

May 31, 1991

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

June 28, 2002

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998